SEEING THE NEED FOR STREAMLINING AND CENTRALISING TRAINING FOR GASTROENTEROLOGISTS
With
Dr Amit Saha
Paediatric Gastroenterologist and Hepatologist,
Hollywood Private Hospital, Nedlands, WA &
Director of Clinical Training in Paediatrics, St John of God Midland Hospital, Midland, WA & Senior Clinical Lecturer, Curtin University
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Perth | January 2026
Dr Amit Saha is a Paediatric Gastroenterologist and Hepatologist and trained paediatric endoscopist based in Perth. He underwent his higher specialist training in Paediatrics within the NHS in the UK, and sub-specialised in Paediatric Gastroenterology Hepatology & Nutrition at busy and prestigious centres in London including The Kings College Hospital.
After coming to Australia, he also worked as a full time Consultant Gastroenterologist at the Royal Children’s Hospital (RCH Melbourne) till the end of 2020, working within a world class team at one of the great Children’s Hospitals.
Currently he has relocated back to Perth and holds a public appointment at St John of God Midland Hospital, where he is also the Director of Clinical Training in Paediatrics; and offers his services as a paediatric gastroenterologist in his private rooms. Apart from clinical work, he also has a passion for teaching and has a postgraduate certificate in medical education from the UK and holds an academic appointment as senior clinical lecturer with Curtin University.
Amit has extensive experience in managing all aspects of paediatric gastroenterology, with expertise in common childhood problems such as chronic constipation, encopresis, chronic abdominal pain, reflux, poor weight gain, feeding difficulties, celiac disease, problems of the oesophagus, IBD, liver and nutrition related problems.
Source: Supplied
-
Bionic eye trial shows improvements in functional vision for retinitis pigmentosa
Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and quality of life over a period of more than two and a half years.
Led by the Centre for Eye Research Australia, Bionics Institute, University of Melbourne and Royal Victorian Eye and Ear Hospital, the trial findings add to interim results which showed that the second-generation bionic eye developed by Australian company Bionic Vision Technologies provided rapid improvements for four patients with blindness caused the genetic eye condition retinitis pigmentosa.
-
The world of AI avatars in dementia care
Dementia care is one of the critical issues facing the aged care industry. About 500,000 Australians currently live with the brain disorder condition, and this is tipped to rise to 1.1 million in a generation.
How to effectively provide quality care for people living with dementia was a key element of the royal commission into aged care, which found the complex care required was an ongoing challenge for the industry.
-
Foundation outlines breast cancer research strategy
Australian Health Journal met with Associate Professor Cleola Anderiesz, CEO of the National Breast Cancer Foundation to hear of the new 5 year Pink Horizon research strategy. Those with lived experience of breast cancer, along with researchers, clinicians, and other funding organisations, have contributed to the development of the foundation’s new five-year Pink Horizon research strategy. This ambitious plan aims to invest $125 million to accelerate research efforts towards the vision of ending deaths from breast cancer.
